25 years isn’t just a milestone. It has included collaboration with many passionate people in the medical community. We look forward to continuing to advance patient care for years to come — because 25 years is only the beginning.*

Looking back at 25 years of looking forward

*First commercial approval, CE Mark in September 1997.

GORE EXCLUDER AAA Endoprosthesis

440,000+ patients treated worldwide

25 years of advancing patient care: One man shares how the continued innovation of the EXCLUDER® Device family made a difference in his life.

Watch now (4:44)

Video Thumbnail

Most studied EVAR device

25 years of supporting post-trial follow-up: Dr. Ross Milner discusses why continued studies are helping advance aortic treatment.

Watch now (4:40)

video thumbnail

Over 1,500 peer-reviewed publications

25 years of peer-reviewed publications: how one registry continues to contribute EVAR insights through literature.

Watch now (0:26)

† Based on the number of Trunk-Ipsilateral Legs distributed. 
‡ Based on company-sponsored trials and registries shown on clinicaltrials.gov for currently available stent grafts.


Learn more about our family of EVAR solutions you can count on:
GORE® EXCLUDER® Iliac Branch Endoprosthesis
GORE® EXCLUDER® Conformable AAA Endoprosthesis


GORE EXCLUDER AAA Endoprosthesis